Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration, the Biden campaign and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Kaiser Family Foundation

Summary of Low-Income Subsidy Program in Final Medicare Bill

This one page document summarizes the provisions in the new Medicare law that deal with providing financial subsidies to low-income beneficiaries for their drug coverage.Issue Paper (.pdf)

Fact Sheet Read More
Kaiser Family Foundation

Implications of the New Medicare Prescription Drug Benefit for State Medicaid Budgets

For a number of years, Governors and other state policymakers have maintained that Medicare – rather than state Medicaid programs – should play the key role in providing prescription drug coverage to Medicare beneficiaries, including those who also qualify for Medicaid because they are impoverished and/or have extensive health care…

Issue Brief Read More
Kaiser Family Foundation

Understanding the Health-Care Needs and Experiences of People with Disabilities:  Findings from a 2003 Survey

Understanding the Health-Care Needs and Experiences of People with Disabilities: Findings from a 2003 SurveyPeople with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people…

Report Read More
Kaiser Family Foundation

The Role of Health Coverage for People with Disabilities

People with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing…

Event Read More
Kaiser Family Foundation

Medicare Prescription Drugs and Low-Income Beneficiaries – Presentation

Summary of Low-Income Subsidy Program in Final Medicare BillThis presentation summarizes the dual eligible population, the low-income provisions of the new Medicare drug benefit and discusses the impact on state Medicaid programs.Presentation Slides (.pdf)

Event Read More
Kaiser Family Foundation

Prescription Drug Coverage for Medicare Beneficiaries: A Summary of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

This document, prepared by Health Policy Alternatives, Inc., provides a detailed summary of the prescription drug provisions of the Medicare legislation (P.L. 108-173) signed by the President on December 8, 2003.Report (.pdf)

Report Read More
Kaiser Family Foundation

Dual Eligibles in Nursing Facilities and Medicare Drug Coverage

This Briefing Note explores the issues presented for the design and administration of a new Medicare drug benefit by dually eligible nursing facility residents.Issue Paper (.pdf)

Issue Brief Read More
Kaiser Family Foundation

Standard Medicare Drug Benefit, 2006 Chart

Standard Medicare Drug Benefit, 2006Out-of-pocket drug spending for Medicare beneficiaries under the standard Medicare drug benefit described in the Medicare Modernization Act of 2003. Chart (.pdf)

Report Read More
Kaiser Family Foundation

Prescription Drug Coverage for Medicare Beneficiaries: A Side-by-Side Comparison of S. 1 and H.R. 1 and the Conference Agreement H.R. 1

This document, prepared by Health Policy Alternatives, Inc., provides a detailed side-by-side comparison of the prescription drug provisions of the Conference Agreement (H.R. 1) passed by the House and Senate in November 2003 and the House (H.R. 1) and Senate (S. 1) Medicare proposals passed in June 2003.Report (.pdf)

Report Read More
Kaiser Family Foundation

Shifting the Cost of Dual Eligibles: Implications for States and the Federal Government

This issue paper provides state-level estimates on spending on dual eligibles and illustrates the fiscal effects of scenarios where the federal government assumes the cost of prescription drugs, Medicare premiums, acute care, and long-term care for this population.Issue Paper (.pdf)

Issue Brief Read More

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.